OSE Immunotherapeutics Share Price Börse Stuttgart
Stocks
6OP
FR0012127173
Biotechnology & Medical Research
OTC Markets Traded|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 3.264 EUR | -1.45% |
|
-10.82% | -34.35% |
| 06-11 | OSE Immunotherapeutics Recovers Following Oddo BHF Endorsement |  |
| 06-10 | OSE Immunotherapeutics SA - Special Call |
| Market Cap | 77.52M 88.24M 71.88M 66.1M 125M 8.44B 128M 857M 335M 4.14B 331M 324M 14.33B | P/E 2026 * |
-2.53x | P/E 2027 * | -2.9x |
|---|---|---|---|---|---|
| Enterprise Value | 118M 135M 110M 101M 191M 12.88B 195M 1.31B 512M 6.32B 506M 495M 21.88B | EV / Sales 2026 * |
24.1x | EV / Sales 2027 * | 13.4x |
| Free-Float |
74.23% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: OSE Immunotherapeutics
| 1 week | -8.93% | ||
| Current month | +5.29% | ||
| 1 month | -16.01% | ||
| 3 months | +3.68% | ||
| 6 months | -33.00% | ||
| Current year | -35.30% |
| 1 week | 3.25 |  | 3.64 |
| 1 month | 2.99 | | 4.03 |
| 3 years | 2.65 | | 10.74 |
| 5 years | 2.65 | | 13.46 |
| 10 years | 2.65 | | 15.15 |
| Manager | Title | Age | Since |
|---|---|---|---|
Marc Bozec
CEO | Chief Executive Officer | - | 01/10/2025 |
Thomas Gidoin
DFI | Director of Finance/CFO | 43 | 19/08/2025 |
Silvia Comis
CTO | Chief Tech/Sci/R&D Officer | - | 19/12/2021 |
| Director | Title | Age | Since |
|---|---|---|---|
Maryvonne Hiance
BRD | Director/Board Member | 77 | 30/05/2016 |
Brigitte Dreno
BRD | Director/Board Member | 73 | 13/06/2017 |
| Director/Board Member | - | 21/06/2023 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -1.45% | -10.82% | -34.92% | -5.66% | 89.33M | |
| +0.44% | +2.51% | +4.36% | +10.27% | 50.73B | |
| -1.57% | -2.80% | +383.82% | +582.81% | 39.73B | |
| -0.14% | +0.25% | +27.49% | -5.23% | 34.69B | |
| +1.76% | +2.12% | +21.44% | +58.27% | 33.21B | |
| -0.06% | -4.63% | +2.94% | +31.65% | 26.76B | |
| -1.93% | -3.38% | - | - | 16.8B | |
| -1.49% | -4.92% | +63.89% | +119.25% | 15.37B | |
| +0.78% | +0.20% | +14.69% | +17.08% | 13.78B | |
| -0.97% | -4.02% | +10.35% | -31.69% | 12.85B | |
| Average | -0.19% | -0.98% | +54.90% | +86.31% | 27.1B | |
| Weighted average by Cap. | +0.05% | -0.38% | +81.55% | +122.96% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 4.9M 5.58M 4.54M 4.18M 7.89M 534M 8.06M 54.2M 21.19M 262M 20.94M 20.48M 906M | 10.53M 11.99M 9.76M 8.98M 16.96M 1.15B 17.33M 116M 45.55M 563M 45M 44.02M 1.95B |
| Net income | -30.59M -34.82M -28.36M -26.08M -49.27M -3.33B -50.32M -338M -132M -1.63B -131M -128M -5.66B | -21.47M -24.44M -19.9M -18.3M -34.58M -2.34B -35.32M -237M -92.86M -1.15B -91.74M -89.74M -3.97B |
| Net Debt | 40.79M 46.43M 37.82M 34.78M 65.71M 4.44B 67.11M 451M 176M 2.18B 174M 171M 7.54B | 63.08M 71.81M 58.49M 53.79M 102M 6.87B 104M 698M 273M 3.37B 270M 264M 11.66B |
| Date | Price | Change |
|---|---|---|
| 13/07/26 | €3.264 | -1.45% |
| 10/07/26 | €3.312 | -2.13% |
| 09/07/26 | €3.384 | +0.53% |
| 08/07/26 | €3.366 | +1.69% |
| 07/07/26 | €3.310 | -7.65% |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Annual profits - Rate of surprise
- Stock Market
- Stocks
- OSE Stock
- 6OP Stock
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
